Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy

We investigated the safety and efficacy of a methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) combination regimen as second-line chemotherapy for patients with advanced or metastatic transitional cell carcinoma who failed first-line gemcitabine and cisplatin (GC) chemotherapy. Thirty pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, K S, Joung, J Y, Kim, T S, Jeong, I G, Seo, H K, Chung, J, Lee, K H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359702/
https://www.ncbi.nlm.nih.gov/pubmed/18087289
http://dx.doi.org/10.1038/sj.bjc.6604113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359702/
https://www.ncbi.nlm.nih.gov/pubmed/18087289
http://dx.doi.org/10.1038/sj.bjc.6604113

Ejemplares similares